Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
第一作者:
Kevin,Kalinsky
第一单位:
Winship Cancer Institute, Emory University, Atlanta, GA.
作者:
医学主题词
人类(Humans);女(雌)性(Female);乳腺肿瘤(Breast Neoplasms);细胞周期蛋白依赖激酶4(Cyclin-Dependent Kinase 4);前瞻性研究(Prospective Studies);双盲法(Double-Blind Method);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞周期蛋白依赖激酶6(Cyclin-Dependent Kinase 6)
DOI
10.1200/JCO.22.02392
PMID
37207300
发布时间
2023-08-21
- 浏览5
Journal of clinical oncology
4004-4013页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



